Back to Search Start Over

Detection of colon cancer recurrences during follow-up care by general practitioners versus surgeons

Authors :
Vos, Julien A. M.
Sert, Eda
Busschers, Wim B.
Duineveld, Laura A. M.
Wieldraaijer, Thijs
Wind, Jan
Donkervoort, Sandra C.
Govaert, Marc
Beverdam, Frédérique H.
Smits, Anke
Bemelman, Wilhelmus A.
Heuff, Gijsbert
van Weert, Henk C. P. M.
van Asselt, Kristel M.
General practice
Graduate School
APH - Personalized Medicine
CCA - Cancer Treatment and Quality of Life
APH - Methodology
Amsterdam Gastroenterology Endocrinology Metabolism
Surgery
APH - Quality of Care
ACS - Heart failure & arrhythmias
CCA - Imaging and biomarkers
AGEM - Amsterdam Gastroenterology Endocrinology Metabolism
Source :
Journal of the National Cancer Institute. Oxford University Press, Journal of the National Cancer Institute, 115(5), 523-529. Oxford University Press
Publication Year :
2023

Abstract

Background In the I CARE study, colon cancer patients were randomly assigned to receive follow-up care from either a general practitioner (GP) or a surgeon. Here, we address a secondary outcome, namely, detection of recurrences and effect on time to detection of transferring care from surgeon to GP. Methods Pattern, stage, and treatment of recurrences were described after 3 years. Time to event was defined as date of surgery, until date of recurrence or last follow-up, with death as competing event. Effects on time to recurrence and death were estimated as hazard ratios (HRs) using Cox regression. Restricted mean survival times were estimated. Results Of 303 patients, 141 were randomly assigned to the GP and 162 to the surgeon. Patients were male (67%) with a mean age of 68.0 (8.4) years. During follow-up, 46 recurrences were detected; 18 (13%) in the GP vs 28 (17%) in the surgeon group. Most recurrences were detected via abnormal follow-up tests (74%) and treated with curative intent (59%). Hazard ratio for recurrence was 0.75 (95% confidence interval [CI] = 0.41 to 1.36) in GP vs surgeon group. Patients in the GP group remained in the disease-free state slightly longer (2.76 vs 2.71 years). Of the patients, 38 died during follow-up; 15 (11%) in the GP vs 23 (14%) in the surgeon group. Of these, 21 (55%) deaths were related to colon cancer. There were no differences in overall deaths between the groups (HR = 0.76, 95% CI = 0.39 to 1.46). Conclusion Follow-up provided by GPs vs surgeons leads to similar detection of recurrences. Also, no differences in mortality were found.

Subjects

Subjects :
Cancer Research
Oncology

Details

Language :
English
ISSN :
00278874
Database :
OpenAIRE
Journal :
Journal of the National Cancer Institute. Oxford University Press, Journal of the National Cancer Institute, 115(5), 523-529. Oxford University Press
Accession number :
edsair.doi.dedup.....722027b8230a882a8faf28672e65a536